Basket | Login

 
 
 
 

Phase II trials

Clinical Trials Watch

This section contains information about clinical trials that are:

  • Currently recruiting participants
  • Conducted at least in one European country
  • In phase II (in these trials the drug / treatment is tested in groups involving up to several hundred participants with the disease/condition. These trials are conducted to explore the therapeutic efficacy of the drug / treatment in participants.)

How many Phase II trials are reported in the CTW?

The CTW reports currently 10 ongoing Phase II clinical trials recruiting participants in Europe. These trials are listened in the table below:

Study

Study sponsor

Name of the drug

Condition

Abvac40

Araclon Biotech S.L.

ABvac40

Amnestic mild cognitive impairment or very mild Alzheimer's disease

ACI-24-1801

AC Immune

ACI-24

Mild Alzheimer's disease

ACI-35.030

AC Immune

ACI-35.030

Early Alzheimer's disease

ALZ-801

Alzheon Inc.

ALZ-801

Early Alzheimer's disease

DESPIAD

University College London

CPHPC

Mild Alzheimer's disease

ETHERAL

Oryzon

ORY-2001

Mild-moderate Alzheimer's disease

GRADUATION

Roche

Gantenerumab 

Early Alzheimer's disease 

T-817MA

FUJIFILM

T-817MA

Mild cognitive impairment due to Alzheimer's disease or mild Alzheimer's disease

TRAILBLAZER-ALZ 2

Eli Lilly

Donanemab

Early Alzheimer's disease

VIVIAD

Vivoryon Therapeutics AG

PQ912

Mild cognitive impairment and mild dementia due to Alzheimer 's Disease

 

 
 

Last Updated: Wednesday 06 January 2021

 

 
  • Acknowledgements

    Alzheimer Europe's Clinical Trial Watch received funding under an operating grant from the European Union’s Health Programme (2014–2020).
  • European Union
 
 

Options